Constitutive meeting of the Board of Directors of Herantis Pharma Plc

Constitutive meeting of the Board of Directors of Herantis Pharma Plc

Herantis Pharma Plc
Company release 10 April 2015 at 10:00 AM

Convening after the Annual General Meeting on 9 April 2015, the Board of Directors of Herantis Pharma elected Pekka Mattila as Chairman.

HERANTIS PHARMA PLC

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225

About Herantis Pharma Plc

Herantis Pharma Plc is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson’s disease, and secondary lymphedema. We believe our drugs are the first or best in their class and have the potential to change treatment strategies of diseases. The shares of Herantis Pharma Plc are listed on the First North Finland marketplace run by NASDAQ Helsinki stock exchange.